In a year, we’ll be certain about the next steps
What stage is the research at now?
We have completed several trials proving that this method works. The OPTEL-MED project aims to demonstrate this method in several animal models, and we’ve succeeded. We have tested it on insects and rodents and are preparing for tests on pigs, which is the final step before clinical application. Testing on large animals is financially and time-intensive, so we want to pinpoint a specific application before diving into it. Scientifically, it’s a success. We’ve published many quality papers, and the response from the scientific community has been very positive. However, now we are considering which applications make the most business sense. OPTEL-MED ends at the end of 2025, which is just around the corner. So we’re contemplating what the next step will look like. I think within a year, we’ll know for sure what comes next.
What applications are you considering?
The initial idea was to target the cervical region of the vagus nerve, whose stimulation is used for treating various forms of epilepsy or inflammatory diseases, especially Crohn’s disease. Studies have shown that vagus nerve stimulation completely changed patients' lives, and I’ve met a few such individuals. Currently, it is done by implanting a pacemaker-like device under the collarbone, with wires leading to the vagus nerve in the neck. However, the surgery is highly complex and invasive, with only a few surgeons willing to perform it.
Your stimulator is significantly smaller, so the procedure could be simpler and less invasive?
It’s a plastic component that looks like tape. The thickness is a few micrometers, about a tenth of a human hair. The problem is that the nerve still needs to be isolated, and even with a minimal component, we cannot bypass the complex surgical procedure. Therefore, we are collaborating with surgeons to find an implantation method, as the technology’s success depends on it. We are exploring applications that don’t require such complex surgical implantation.
What other possibilities are there?
We’re also considering stimulating the cerebral cortex. Some of the most interesting indications are psychiatric illnesses, such as depression. Currently, patients visit the hospital weekly for brain stimulation, but with our implant, they could perform the stimulation at home. Also, implantation on the brain’s surface is currently very simple, or at least simpler than implantation on the vagus nerve. We’re also considering applications for chronic pain or migraines.